Biotage Launches ACI™ - Accelerated Chromatographic Isolation

Biotage announces the launch of ACI™ (Accelerated Chromatographic Isolation), a new advance converting simple flash purification into a faster and more economical way to isolate pure compounds.

Uppsala, Sweden (July 10, 2014) -- Biotage (STO: BIOT), a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, announces the launch of ACI™ (Accelerated Chromatographic Isolation), a new advance converting simple flash purification into a faster and more economical way to isolate pure compounds.

Biotage believes that ACI™ will radically improve the efficiency of the laboratory, embracing the latest developments in purification technology to guide chemists towards improved chromatography. With running costs a concern in most laboratories, ACI™ will efficiently move users to the end-point even faster. Traditional purification taking more than 15 minutes is reduced to 5 minutes; a 250 mg scale laboratory scale experiment can now be purified in less than 3 minutes on a 10 g column with an ACI™ enabled Biotage Isolera™ flash purification system.

"This is a very exciting and pivotal development, the speed enhancements are akin to the impact felt when microwaves first hit the scene. There is nothing out there that comes close to this system. Chemists will now have freedom to work on other things while they let their ACI™ system do the purification. It is fully automated, reliable and lightning fast, we can completely purify 250 mg of sample in less than 3 minutes, this is quicker than most people take to run the TLC" says Dr Sunil Rana, Global Product Manager, Biotage.

Biotage Isolera™ systems already recommend cartridges based on the sample size and programmed TLC data; they work out the best solvent gradient based on compound, and provide real time indication of eluting compounds, using UV, ELSD or Mass Detection. They subtract signal baselines automatically, so chemists can be confident that the correct fractions are collected.

ACI™ radically improves this, working seamlessly with the Biotage Isolera™ system, the simple wizard quickly guides chemists through the system, beneficial for new users or those whose expertise or priorities lie in synthesis rather than purification. Existing Biotage Isolera systems can be upgraded to ACI™ systems, and ACI™ will come as standard on all new production systems.

For further information visit http://www.biotage.com or call:

In Europe: +46 18 56 57 10

In North America: (Toll Free) 1 800 446 4752

In Japan: +81 422 28 1233

Other areas, please call: +46 18 56 57 10

-Ends-

For further press information from Biotage please contact:

James Churchill

Marketing Communications

Biotage GB Limited

Distribution Way

Dyffryn Business Park

Ystrad Mynach

Hengoed, Wales CF82 7TS

United Kingdom

Tel: +44 (0)1443 811 849

Mobile: +44(0)7875484778

E-Mail: james.churchill@biotage.com

About Biotage

Biotage offers solutions, knowledge and experience in the areas of analytical and medicinal chemistry. Customers include the world's top pharmaceutical and biotechnology companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, with offices in China, Japan, the United Kingdom, the United States and a worldwide network of distributors. Biotage has 290 employees with sales of 444.6 MSEK in 2013. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange. Website: http://www.biotage.com.